These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3518936)

  • 1. Adverse effects of the treatment for hyperlipidemia.
    Malinow MR
    Cardiol Clin; 1986 Feb; 4(1):95-103. PubMed ID: 3518936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary recommendations for evaluating and treating hyperlipidemia.
    Perry RS
    Clin Pharm; 1986 Feb; 5(2):113-27. PubMed ID: 3514084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of lipid disorders.
    Knopp RH
    N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating hyperlipidemia, Part III: Drug therapy.
    Smith DA; Karmally W; Brown WV
    Geriatrics; 1987 Aug; 42(8):55-9, 62. PubMed ID: 3110017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1985 Aug; 27(695):74-6. PubMed ID: 3860714
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to treat hyperlipidemia.
    Kane JP; Malloy MJ
    Adv Intern Med; 1988; 33():143-63. PubMed ID: 3278503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current dietetic and pharmacological treatment of hyperlipoproteinemia].
    Caruzzo C
    Minerva Med; 1975 Dec; 66(84):4527-34. PubMed ID: 1105243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of nutritional risks of special diets and drugs used in the management of familial hypercholesterolemia.
    Roe DA
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):151-9. PubMed ID: 3519931
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of hyperlipidemia and the role of probucol.
    Davignon J
    Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J
    Arch Intern Med; 2004 Apr; 164(7):697-705. PubMed ID: 15078639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266
    [No Abstract]   [Full Text] [Related]  

  • 17. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.
    Layne RD; Sehbai AS; Stark LJ
    Ann Pharmacother; 2004 Feb; 38(2):232-4. PubMed ID: 14742756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
    Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.